Partnering for Progress in Psychedelic-Based Care
As interest in psychedelic medicine grows, patients and providers alike face a landscape of both hope and misinformation. At PSI, we understand your commitment to your patients and need for partnerships built on scientific rigor, ethical practice, and transparent collaboration. We honor your existing treatment goals and invite a partnership that advances healing responsibly.
Why Partner with PSI TRIP Clinics?
Our PSI TRIP Clinics represent the merging of experience with innovation in psychedelic care. Our foundation is built on decades of expertise in psychiatry, neuroscience, and clinical trial ethics, with a team certified in trauma-informed and culturally responsive care. We are more than a typical treatment center. We offer ketamine-assisted psychotherapy (KAP) while also are conducting clinical trials focused on developing the next generation of mental health care and psychedelic medicines for mental health and neuroscience conditions.
- Expert, Multidisciplinary Care: At PSI TRIP Clinics, all care, whether a clinical treatment protocol such as KAP or a clinical trial, is provided by licensed, highly experienced clinicians trained in psychedelic-assisted therapy, trauma-informed care, and mental health best practices. Our team includes physicians, psychologists, psychotherapists, psychiatric nurses, and other mental health professionals working collaboratively to ensure comprehensive support.
- Science-Backed, Ethical Practices: Our services are legal, evidence-informed, and patient-centered. Treatment protocols are grounded in clinical practice guidelines, peer-reviewed research, and our clinical trials follow FDA-aligned regulatory standards. As leaders in providing ethical psychedelic-based care, we uphold the highest standards of safety, transparency, and scientific rigor, while not endorsing or providing illegal substances.
- Patient-Centered Care Design: We embrace a relational and individualized “set and setting” framework to optimize the therapeutic process, ensuring each patient is thoroughly screened, consented, prepared, and supported throughout their care. This approach promotes trust, safety, and improved outcomes, while reducing dropout rates in both clinical care and clinical trial settings.
- Seamless Provider Collaboration: We work in close partnership with referring providers to ensure continuity of care. Our team offers clear, consistent communication, including informed consent processes, collaborative treatment planning, outcome sharing, and warm handoffs following treatment completion.
Referral Opportunities
PSI TRIP Clinics offer both treatments with psychedelic-assisted therapy and innovative clinical trial opportunities for conditions that may not have responded to other available therapies.
Ketamine-Assisted Psychotherapy (KAP)
Conditions Treated: Major Depression, Treatment-Resistant Depression, Post-Traumatic Stress Disorder (PTSD), Anxiety disorders, Obsessive-Compulsive Disorder (OCD), Bipolar Depression, Adjustment DIsorders and End-of-Life Psychological Care, Palliative Care, Drug and Alcohol Use Disorders.
Process: KAP involves a series of in-clinic ketamine-assisted psychotherapy sessions conducted by licensed medical and psychological health care providers. Patients must be California residents and attend in-person dosing sessions at our Santa Monica or Hollywood TRIP Clinics.
Cost: Ketamine dosing sessions are $600 out-of-pocket, 2 times a week for 8 weeks. Ketamine is FDA-approved as an anesthetic and used "off-label" for KAP.
Psychedelic Integration Therapy
Designed to support the synthesis of mind and body after experiencing non-ordinary states of consciousness. This service is for patients seeking to process psychedelic experiences from a range of various contexts — ceremonial, recreational and/or medical — offering a harm-reduction approach and clinical support for meaningful change.
Psychotherapy
Our team of trauma-informed psychotherapists offers comprehensive, depth-oriented psychotherapy, including Transpersonal, Supportive, Interpersonal, and Psychodynamic approaches.
Psychotherapy is an effective treatment for people experiencing a wide range of mental health challenges, from depression, traumatic stress and anxiety to relationship challenges and other existential crises.
Medication Management
Our medical team provides evaluation, consultation and supervision of medication regimens, focusing on maximizing quality of life with the minimum necessary treatment. This can be combined with psychotherapy to optimize outcomes or offered as a stand alone treatment option.
Psychedelic-Assisted Clinical Trials
PSI is actively involved in clinical trials for multiple psychedelic compounds including psilocybin, LSD DMT, and other novel psychedelics. Available trials vary at times, but may include studies for Major Depressive Disorder, Treatment-Resistant Depression, Generalized Anxiety Disorder and PTSD.
View currently-enrolling trials
Past Completed Trials include studies for Post Traumatic Stress Disorder, Generalized Anxiety Disorder, Treatment Resistant Depression, Major Depressive Disorder, Postpartum Depression and Alcohol Use Disorder.
Important Note: MDMA, psilocybin, LSD and DMT have not been approved by any regulatory agency. The safety and efficacy of these investigational products have not yet been fully established for the treatment of any health conditions. PSI clinicians have extensive research experience with these emerging treatments.
How to Refer:
Telehealth: Our specialists offer HIPAA-compliant telehealth visits for patients anywhere in California for psychotherapy services. Ketamine-assisted psychotherapy, clinical trials and medication management services all require onsite, in clinic visits.
Partner with PSI
We welcome collaboration and are ready to discuss how PSI can serve as a valuable extention of your patient care.
To learn more or to discuss referring a patient:
- For Ketamine Treatment: 310-996-8966
- For Psychedelic-Assisted Clinical Trials: 310-378-0303